These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35491674)

  • 1. FGF21 response to sucrose is associated with BMI and dorsal striatal signaling in humans.
    Alves JM; Yunker AG; Luo S; Jann K; Angelo B; DeFendis A; Pickering TA; Smith A; Monterosso JR; Page KA
    Obesity (Silver Spring); 2022 Jun; 30(6):1239-1247. PubMed ID: 35491674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and Sex-Related Associations With Differential Effects of Sucralose vs Sucrose on Appetite and Reward Processing: A Randomized Crossover Trial.
    Yunker AG; Alves JM; Luo S; Angelo B; DeFendis A; Pickering TA; Monterosso JR; Page KA
    JAMA Netw Open; 2021 Sep; 4(9):e2126313. PubMed ID: 34581796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meal sugar-protein balance determines postprandial FGF21 response in humans.
    Ramne S; Duizer L; Nielsen MS; Jørgensen NR; Svenningsen JS; Grarup N; Sjödin A; Raben A; Gillum MP
    Am J Physiol Endocrinol Metab; 2023 Nov; 325(5):E491-E499. PubMed ID: 37729024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF21 Is a Sugar-Induced Hormone Associated with Sweet Intake and Preference in Humans.
    Søberg S; Sandholt CH; Jespersen NZ; Toft U; Madsen AL; von Holstein-Rathlou S; Grevengoed TJ; Christensen KB; Bredie WLP; Potthoff MJ; Solomon TPJ; Scheele C; Linneberg A; Jørgensen T; Pedersen O; Hansen T; Gillum MP; Grarup N
    Cell Metab; 2017 May; 25(5):1045-1053.e6. PubMed ID: 28467924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF21 Mediates Endocrine Control of Simple Sugar Intake and Sweet Taste Preference by the Liver.
    von Holstein-Rathlou S; BonDurant LD; Peltekian L; Naber MC; Yin TC; Claflin KE; Urizar AI; Madsen AN; Ratner C; Holst B; Karstoft K; Vandenbeuch A; Anderson CB; Cassell MD; Thompson AP; Solomon TP; Rahmouni K; Kinnamon SC; Pieper AA; Gillum MP; Potthoff MJ
    Cell Metab; 2016 Feb; 23(2):335-43. PubMed ID: 26724858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity.
    Tan BK; Hallschmid M; Adya R; Kern W; Lehnert H; Randeva HS
    Diabetes; 2011 Nov; 60(11):2758-62. PubMed ID: 21926274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and Dietary Added Sugar Interact to Affect Postprandial GLP-1 and Its Relationship to Striatal Responses to Food Cues and Feeding Behavior.
    Jones S; Luo S; Dorton HM; Yunker AG; Angelo B; Defendis A; Monterosso JR; Page KA
    Front Endocrinol (Lausanne); 2021; 12():638504. PubMed ID: 33868172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 21 and dietary macronutrient intake in female mice.
    Wu CT; Larson KR; Goodson ML; Ryan KK
    Physiol Behav; 2022 Dec; 257():113995. PubMed ID: 36240865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor 21, adiposity, and macronutrient balance in a healthy, pregnant population with overweight and obesity.
    Sutton EF; Morrison CD; Stephens JM; Redman LM
    Endocr Res; 2018 Nov; 43(4):275-283. PubMed ID: 29768065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic high-sucrose diet increases fibroblast growth factor 21 production and energy expenditure in mice.
    Maekawa R; Seino Y; Ogata H; Murase M; Iida A; Hosokawa K; Joo E; Harada N; Tsunekawa S; Hamada Y; Oiso Y; Inagaki N; Hayashi Y; Arima H
    J Nutr Biochem; 2017 Nov; 49():71-79. PubMed ID: 28886439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary sugars and non-caloric sweeteners elicit different homeostatic and hedonic responses in the brain.
    van Opstal AM; Kaal I; van den Berg-Huysmans AA; Hoeksma M; Blonk C; Pijl H; Rombouts SARB; van der Grond J
    Nutrition; 2019 Apr; 60():80-86. PubMed ID: 30529886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating FGF21 in humans is potently induced by short term overfeeding of carbohydrates.
    Lundsgaard AM; Fritzen AM; Sjøberg KA; Myrmel LS; Madsen L; Wojtaszewski JFP; Richter EA; Kiens B
    Mol Metab; 2017 Jan; 6(1):22-29. PubMed ID: 28123934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic Fat Content Is Associated with Fasting-Induced Fibroblast Growth Factor 21 Secretion in Mice Fed Soy Proteins.
    Taniguchi H; Akiyama N; Ishihara K
    J Nutr Sci Vitaminol (Tokyo); 2019; 65(6):515-525. PubMed ID: 31902865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in serum fibroblast growth factor-21 after gastric bypass is related to changes in hepatic fat content.
    Fjeldborg K; Pedersen SB; Møller HJ; Richelsen B
    Surg Obes Relat Dis; 2017 Sep; 13(9):1515-1523. PubMed ID: 28552744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.
    Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F
    Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose tissue contribution to plasma fibroblast growth factor 21 and fibroblast activation protein in obesity.
    van Baak MA; Vink RG; Roumans NJT; Cheng CC; Adams AC; Mariman ECM
    Int J Obes (Lond); 2020 Feb; 44(2):544-547. PubMed ID: 31455871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher fasting plasma FGF21 concentration is associated with lower ad libitum soda consumption in humans.
    Basolo A; Hollstein T; Shah MH; Walter M; Krakoff J; Votruba SB; Piaggi P
    Am J Clin Nutr; 2021 Oct; 114(4):1518-1522. PubMed ID: 34159373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels.
    Cuevas-Ramos D; Almeda-Valdes P; Gómez-Pérez FJ; Meza-Arana CE; Cruz-Bautista I; Arellano-Campos O; Navarrete-López M; Aguilar-Salinas CA
    Eur J Endocrinol; 2010 Sep; 163(3):469-77. PubMed ID: 20566587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.
    Dushay J; Chui PC; Gopalakrishnan GS; Varela-Rey M; Crawley M; Fisher FM; Badman MK; Martinez-Chantar ML; Maratos-Flier E
    Gastroenterology; 2010 Aug; 139(2):456-63. PubMed ID: 20451522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liraglutide Decreases Liver Fat Content and Serum Fibroblast Growth Factor 21 Levels in Newly Diagnosed Overweight Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.
    Li X; Wu X; Jia Y; Fu J; Zhang L; Jiang T; Liu J; Wang G
    J Diabetes Res; 2021; 2021():3715026. PubMed ID: 34660809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.